Yiwen Wu

Also affiliated with Jishou University, National Yang Ming Chiao Tung University, Shanghai Jiao Tong University, Ruijin Hospital, Mackay Memorial Hospital, National Taiwan University Hospital, Taipei Medical University, Beijing University of Chemical Technology, Nanjing Medical University, Ministry of Industry and Information Technology

MedicineNeuroscienceEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitors using an artificial intelligence model and their effects on tau and tubulin dynamics”.

Discovery of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitors using an artificial intelligence model and their effects on tau and tubulin dynamics

Biomedicine & Pharmacotherapy(2024)10.1016/j.biopha.2024.117688

N/A

0DataRank · unranked

7 citations

Huang‐Ju Tu, Tony Eight Lin, Zhaoxiang Peng, Yiwen Wu, Shih‐Chung Yen +7 more

Identification of a Potent CDK8 Inhibitor Using Structure-Based Virtual Screening

Journal of Chemical Information and Modeling(2024)10.1021/acs.jcim.4c02011

N/A

0DataRank · unranked

6 citations

Ching-Hsuan Chou, Yiwen Wu, Tzu-Ying Sung, Jui-Yi Hsu, Shih‐Chung Yen +7 more

Identification of pyrazole scaffold inhibitors targeting cyclin-dependent kinase 8 for potential use in pulmonary fibrosis

Biochemical Pharmacology(2025)10.1016/j.bcp.2025.116959

N/A

0DataRank · unranked

0 citations

Kai‐Cheng Hsu, Ching-Hsuan Chou, En-Yun Tsai, Yiwen Wu, Tzu-Ying Sung +8 more